drugset / Trial / NCT01764945
Relative Bioavailability of BI 201335 Capsule Versus Three Different Oral Solutions
RandomizedCrossoverOpen-labelTreatment
Summary
The objective of the current study is to investigate the relative bioavailability of two different doses of BI 201335, administered as soft gelatine capsule in comparison to the equivalent doses of three different oral solution per dose of BI 201335.
Timeline
- Start
- 2013-01
- Primary completion
- 2013-03
- Completion
- 2013-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Faldaprevir | Small molecule | — | Oral |
Indications
No indication recorded.